AgFeed Industries, Inc. , the largest commercial hog producer and the largest premix feed company in China, today announced that it will raise gross proceeds of $8.75 million through the sale to institutional investors of 5 million newly issued common stock units at $1.75 per unit under an effective Form S-3 Registration Statement.

Cell Therapeutics, Inc. announced today they have closed the transaction with Spectrum Pharmaceuticals, Inc. to form a 50/50 owned joint venture, RIT Oncology LLC , to commercialize and develop Zevalin® in the United States.

NEW YORK----Rodman & Renshaw Capital Group, Inc. , today announced that it has released an investor presentation regarding its proposed combination with Cowen Group, Inc. The presentation is available through the investor relations page of Rodman’s website and includes additional details of the proposed combination.

NEW YORK----Rodman & Renshaw Capital Group, Inc. , today announced that it will release an investor presentation at 8:00 AM Eastern on Monday, December 15, 2008 regarding its proposed combination with Cowen Group, Inc.

Cowen Group Inc. on Monday rejected an unsolicited bid from rival Rodman & Renshaw Capital Group Inc. to buy the investment bank for nearly $100 million, or $7 per share.

You know youve hit a new bottom when the investment bank trying to take you over has a stock price of a buck and they want to use those shares to buy half of your company, David Weidner writes.

The U.S. financial sector was poised to start the week higher and extend Friday's rally as President-elect Barack Obama's plan to boost infrastructure spending to create jobs lifted global markets.

Cell Therapeutics, Inc. today announced that a single institutional investor shall purchase, for $32.65 million, newly issued 10% Convertible Senior Notes due 2011 , with a conversion price of $0.137 per share.

Spectrum Pharmaceuticals, Inc. and Cell Therapeutics, Inc. announced today they have entered into an agreement to form a 50/50 owned joint venture, RIT Oncology LLC, to commercialize and develop ZEVALIN® in the United States.